The iconic rise of Viagra has long been a example of pharmaceutical success, however its position within the broader sector now raises questions about potential yields . Generic versions are eroding patent protection , prompting concerns that investing in companies heavily reliant to Viagra's previous influence could be a dangerous move , especiall